Celleste Bio Ltd.

Based in Israel, Celleste Bio Ltd. specializes in developing cell-cultured cocoa ingredients using proprietary technology to simulate optimal growing conditions, addressing global chocolate demands sustainably. Celleste Bio Ltd. , founded in 2022, is located in Tel Aviv-Jaffa, Israel.

The company focuses on innovative cocoa ingredient production, having completed 2 deals to date. In December 2024, Celleste Bio raised USD 4. 5 mn in SEED funding, led by Supply Change Capital with participation from several investors including Barrel Ventures and Trendlines Group. The firm was co-founded by Avishai Levy and Hanne Volpin, with Michal B.

serving as CEO. Celleste Bio specializes in the development of cell-cultured cocoa ingredients through its proprietary technology that simulates optimal growing conditions in controlled environments. Their primary offerings include cocoa butter and cocoa powder produced using advanced biotechnological methods. These products are designed to meet the increasing global demand for chocolate while addressing climate change and deforestation challenges.

By utilizing biotechnology, agricultural technology, and artificial intelligence, Celleste Bio provides reliable, high-quality cocoa ingredients tailored to client specifications for various applications, including the confectionery and food industries. Their products serve a diverse clientele, including food manufacturers, chocolatiers, and retailers across North America, Europe, and Asia, ensuring sustainable sourcing without reliance on traditional cocoa-growing practices. Celleste Bio generates revenue through a B2B model, partnering with food manufacturers and retailers for customized cocoa ingredients. Transactions involve direct agreements where clients specify their ingredient needs, leading to production in Celleste Bio's bioreactors.

Clients may opt for recurring orders or contracts based on projected demand, ensuring a stable revenue stream. The company's flagship cell-cultured cocoa butter and powder are priced according to client specifications and volume requirements, supporting both small and large-scale operations. Through these partnerships, Celleste Bio aims to establish long-term customer relationships while promoting sustainable practices in the cocoa industry. In December 2024, Celleste Bio Ltd.

raised USD 4 mn in SEED funding led by Supply Change Capital, with participation from various investors. The funding will be utilized to accelerate research and development, enhance infrastructure, and scale technological capabilities for cell-cultured cocoa production. The company plans to introduce new product lines and expand into additional markets, targeting regions in Europe and Asia by 2025.